Brief: Nautilus Biotechnology Q3 EPS USD -0.13
31/10/2023 12:05
Oct 31 (Reuters) - Nautilus Biotechnology Q3 operating expenses USD 19.075 million. * Q3 net income USD -15.878 million
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11